Inactive Instrument

Highlights Biotech Acquisition Company Nasdaq

Equities

Biotech Acquisition to Dissolve, Liquidate	02/02/23	MT
Biotech Acquisition Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22/11/22	CI
Biotech Acquisition, Blade Therapeutics Agree to Terminate Merger Agreement	13/06/22	MT
Blade Therapeutics, Inc. cancelled the acquisition of Biotech Acquisition Company from Biotech Sponsor LLC and others in a reverse merger transaction.	09/06/22	CI
Biotech Acquisition Postpones Extraordinary Meeting of Shareholders to Approve Proposed Merger With Blade Therapeutics	03/06/22	MT
Biotech Acquisition Company Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22	CI
Blank Check Firm Biotech Acquisition to Merge With Blade Therapeutics	08/11/21	MT
Blade Therapeutics, Inc. entered into a definitive Agreement and Plan of Merger to acquire Biotech Acquisition Company from Biotech Sponsor LLC and others in a reverse merger transaction.	07/11/21	CI
Biotech Acquisition Company has completed an IPO in the amount of $200 million.	25/01/21	CI
Biotech Acquisition Company has filed an IPO in the amount of $200 million.	30/12/20	CI
Biotech Acquisition Company announced that it expects to receive $6 million in funding from Biotech Sponsor LLC	29/12/20	CI

No results for this search